Eargo, Inc. (EAR)
Eargo, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in San Jose, CA, US. The stock last traded at $2.57, down 4.10% on the session, giving a market capitalisation of $53.4M. On trailing twelve-month figures it carries a trailing P/E of -0.06, a net margin of -422.8%. Its beta of 1.48 implies it has historically moved more than the broad market.
Eargo, Inc., a medical device firm, strives to improve the quality of life for individuals experiencing hearing impairment across the United States. The company focuses on developing and distributing hearing aids, utilizing both direct-to-consumer and extensive omni-channel sales approaches. Founded in 2010, the organization initially operated as Aria Innovations, Inc., before officially changing its name to Eargo, Inc. in November 2014. Its primary corporate hub is located in San Jose, California.
Eargo, Inc. is most often compared with the following Healthcare names: